openPR Logo
Press release

Biofilms Treatment Market Worth $2.4 Billion by 2025 | Leading Companies are Smith & Nephew, MiMedx Group Inc, ConvaTec Group plc, and Coloplast A/S

05-14-2020 03:12 PM CET | Health & Medicine

Press release from: MarketsandMarkets

Biofilms Treatment Market Worth $2.4 Billion by 2025 | Leading

According to the new market research report "Biofilms Treatment Market by Products (Debridement Equipment, Gauze, Dressing, Gel, Ointment), Wound Type (Traumatic, Surgical, Open, Diabetic Foot, Venous Leg Ulcer & Burns), End User (Hospital, ASCs, Wound Care Centers, Homecare)-Global Forecast to 2025", published by MarketsandMarkets(TM), the Biofilms Treatment Market is projected to reach USD 2.4 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 7.9%.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=57398610&utm_source=OpenPr&utm_medium=referral&utm_campaign=paidpr

The rising prevalence of chronic, surgical, and traumatic wounds and the increasing incidence of burn injuries are the major factors driving the growth of this market.

Gauzes and dressings segment accounted for the largest share of the biofilms treatment market, by product, in 2020

Based on products, the biofilms treatment market is segmented into debridement equipment; gauzes and dressings; gels, ointments, and sprays; wipes, pads, and lavage solutions; and grafts and matrices. The gauzes and dressings segment accounted for the largest market share in 2019. The large share of this segment is attributed to the ability of antimicrobial products to remove, prevent, and manage biofilms.

Browse in-depth TOC on "Biofilms Treatment Market"
109 - Tables
33 - Figures
150 - Pages
Get 10% Customization on this Research Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=57398610&utm_source=OpenPr&utm_medium=referral&utm_campaign=paidpr

Hospitals, ASCs, and wound care centers segment to register the highest growth in the forecast period

Based on end users, the biofilms treatment market is segmented into hospitals, ASCs, and wound care centers; home care settings, and other end users. The hospitals, ASCs, and wound care centers segment accounted for the largest market in 2019. This segment is also projected to register the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the growing geriatric population and the subsequent increase in the prevalence of age-related conditions and many treatment procedures carried out in hospitals.

North America is the largest regional market for biofilms

Based on region, the biofilms treatment market is segmented into North America, Europe, the Asia Pacific (APAC), Latin America (LATAM), and the Middle East & Africa (MEA). In 2019, North America accounted for the largest share of the biofilms treatment market. The large share of this market can be attributed to the increasing incidence of chronic wounds, rising healthcare expenditure, the introduction of novel and specialty biofilm management products, and the presence of major market players in this region.

Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=57398610&utm_source=OpenPr&utm_medium=referral&utm_campaign=paidpr

Key Players

Prominent players operating in the global biofilms treatment market include Smith & Nephew (UK), MiMedx Group Inc. (US), ConvaTec Group plc (UK), Coloplast A/S (Denmark), Mölnlycke Healthcare AB (Sweden), Organogenesis Holdings Inc. (US), Integra LifeSciences Holdings Corporation (US), B. Braun Melsungen AG (Germany), PAUL HARTMANN AG (Germany), and Medline Industries Inc. (US).

Contact Us
Mr. Aashish Mehra
MarketsandMarkets(TM) INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets
MarketsandMarkets(TM) provides quantified B2B research on 30,000 high growth emerging opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets(TM) for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets(TM) are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets(TM) now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets(TM) is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's(TM) flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biofilms Treatment Market Worth $2.4 Billion by 2025 | Leading Companies are Smith & Nephew, MiMedx Group Inc, ConvaTec Group plc, and Coloplast A/S here

News-ID: 2046005 • Views: …

More Releases from MarketsandMarkets

Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | Marketsand …
Monoclonal Antibody (mABs) Therapeutics Market in terms of revenue was estimated to be worth $252.6 billion in 2024 and is poised to reach $497.5 billion by 2029, growing at a CAGR of 14.5% from 2024 to 2029 according to a new report by MarketsandMarkets™. The monoclonal antibody therapeutics market is primarily driven by factors such as increasing prevalence of chronic diseases like cancer, autoimmune disorders, and infectious diseases. Technological advancements…
Optometry Equipment Market Worth $6.1 billion | MarketsandMarkets™
Optometry Equipment Market Worth $6.1 billion | MarketsandMarkets™
Optometry Equipment Market in terms of revenue was estimated to be worth $4.5 billion in 2024 and is poised to reach $6.1 billion by 2029, growing at a CAGR of 6.4% from 2024 to 2029 according to a new report by MarketsandMarkets™. The principal drivers propelling the expansion of this market are the growing prevalence of eye illnesses, advancements in ophthalmic device technology, expanding government initiatives aimed at preventing visual…
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing R&D investments in cell based research, growing focus on personalized medicine, and increasing number of strategic…
Medical Device Contract Manufacturing Market Worth $149.4 billion | MarketsandMarkets™
Medical Device Contract Manufacturing Market Worth $149.4 billion | MarketsandMa …
Medical Device Contract Manufacturing Market in terms of revenue was estimated to be worth $78.9 billion in 2024 and is poised to reach $149.4 billion by 2029, growing at a CAGR of 11.4% from 2024 to 2029 according to a new report by MarketsandMarkets™. The global population is growing older, leading to an increased demand for medical devices used in diagnostics, treatment, and monitoring of age-related conditions also chronic diseases…

All 5 Releases


More Releases for Biofilms

Europe Biofilms Treatment Market Comprehensive Assessment of Regional Europe Bio …
The research report on Europe Biofilms Treatment Market provides a comprehensive analysis of the market status and development trend, including types, applications, growth, opportunities, rising technology, competitive landscape and product offerings of key players. Europe Biofilms Treatment Market report covers the present and past market scenarios, market development patterns, and is likely to proceed with a continuing development over the forecast period. Sample PDF showcases the content structure and the nature…
Global Biofilms Treatment Market Trends 2019 | Segmentation, Outlook, Industry R …
The global biofilms treatment market is projected to exhibit a significant growth, at a CAGR of around 7.3%, during the forecast period. The major factors that are primarily driving the growth of the market include the increased levels of stress at the workplace, emerging awareness regarding stress management, and growing insurance claims for mental health. As per IHME, in 2017, there was 4.12% of the total population suffering from depression…
Global Biofilms Treatment Market Size, Trends, Industry Report to 2019-2025
Global biofilms treatment market is projected to exhibit a significant growth, at a CAGR of around 7.3%, during the forecast period. The major factors that are primarily driving the growth of the market include the increased levels of stress at the workplace, emerging awareness regarding stress management, and growing insurance claims for mental health. As per IHME, in 2017, there was 4.12% of the total population suffering from depression in…
Biofilms Treatment Market Size, Share, Trends, Analysis and Forecast 2019-2025
The global biofilms treatment market is projected to exhibit a significant growth, at a CAGR of around 7.3%, during the forecast period. The major factors that are primarily driving the growth of the market include the increased levels of stress at the workplace, emerging awareness regarding stress management, and growing insurance claims for mental health. As per IHME, in 2017, there was 4.12% of the total population suffering from depression…
Biofilms Treatment Market Size, Growth, Industry Trends, Share and Forecast 2019 …
The global biofilms treatment market is projected to exhibit a significant growth, at a CAGR of around 7.3%, during the forecast period. The major factors that are primarily driving the growth of the market include the increased levels of stress at the workplace, emerging awareness regarding stress management, and growing insurance claims for mental health. As per IHME, in 2017, there was 4.12% of the total population suffering from depression…
Biofilms Treatment Industry Outlook and Forecast 2020-2025|
This report also researches and evaluates the impact of Covid-19 outbreak on the Biofilms Treatment industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Biofilms Treatment and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.). Global Biofilms Treatment Market Overview: GLOBAL INFO RESEARCH has evaluated the global Biofilms Treatment market in its latest research report. The research report, titled [Global and Japan…